« Sanofi and Genzyme get closer but don’t touch | Main | Boehringer buys Amgen site to expand biologics CMO biz »
Xconomy reports on Dendreon's success in raising an additional $540 M in new capital to support its license application for Provenge in Europe as well as expansion of its European manufacturing footprint for Provenge in USA and Europe.
Posted by Bruce Lehr Jan 15th 2011.
| | |
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0148c7a6b10f970c
Listed below are links to weblogs that reference Dendreon Raises Its $500+ M:
The comments to this entry are closed.
Comments